1QR2 | A:; B: | HUMAN QUINONE REDUCTASE TYPE 2 |
1SG0 | A:; B: | CRYSTAL STRUCTURE ANALYSIS OF QR2 IN COMPLEX WITH RESVERATROL |
1XI2 | A:; B: | QUINONE REDUCTASE 2 IN COMPLEX WITH CANCER PRODRUG CB1954 |
1ZX1 | A:; B: | HUMAN QUINONE OXIDOREDUCTASE 2 (NQO2) IN COMPLEX WITH THE CYTOSTATIC PRODRUG CB1954 |
2QMY | A:; B: | QUINONE REDUCTASE 2 IN COMPLEX WITH ADRENOCHROME |
2QMZ | A:; B: | QUINONE REDUCTASE 2 IN COMPLEX WITH DOPAMINE |
2QR2 | A:; B: | HUMAN QUINONE REDUCTASE TYPE 2, COMPLEX WITH MENADIONE |
2QWX | A:; B: | CRYSTAL STRUCTURE OF QUINONE REDUCTASE II |
2QX4 | A:; B: | CRYSTAL STRUCTURE OF QUINONE REDUCTASE II |
2QX6 | A:; B: | CRYSTAL STRUCTURE OF QUINONE REDUCTASE II |
2QX8 | A:; B: | CRYSTAL STRUCTURE OF QUINONE REDUCTASE II |
2QX9 | A:; B: | CRYSTAL STRUCTURE OF QUINONE REDUCTASE II |
3FW1 | A: | QUINONE REDUCTASE 2 |
3G5M | A:; B: | SYNTHESIS OF CASIMIROIN AND OPTIMIZATION OF ITS QUINONE REDUCTASE 2 AND AROMATASE INHIBITORY ACTIVITY |
3GAM | A:; B: | SYNTHESIS OF CASIMIROIN AND OPTIMIZATION OF ITS QUINONE REDUCTASE 2 AND AROMATASE INHIBITORY ACTIVITY |
3NFR | A:; B: | CASIMIROIN ANALOG INHIBITOR OF QUINONE REDUCTASE 2 |
3NHF | A:; B: | X-RAY CRYSTALLOGRAPHIC STRUCTURE ACTIVITY RELATIONSHIP (SAR) OF CASIMIROIN AND ITS ANALOGS BOUND TO HUMAN QUINONE REDUCTASE 2 |
3NHJ | A:; B: | X-RAY CRYSTALLOGRAPHIC STRUCTURE ACTIVITY RELATIONSHIP (SAR) OF CASIMIROIN AND ITS ANALOGS BOUND TO HUMAN QUINONE REDUCTASE 2 |
3NHK | A:; B: | X-RAY CRYSTALLOGRAPHIC STRUCTURE ACTIVITY RELATIONSHIP (SAR) OF CASIMIROIN AND ITS ANALOGS BOUND TO HUMAN QUINONE REDUCTASE 2 |
3NHL | A:; B: | X-RAY CRYSTALLOGRAPHIC STRUCTURE ACTIVITY RELATIONSHIP (SAR) OF CASIMIROIN AND ITS ANALOGS BOUND TO HUMAN QUINONE REDUCTASE 2 |
3NHP | A:; B: | X-RAY CRYSTALLOGRAPHIC STRUCTURE ACTIVITY RELATIONSHIP (SAR) OF CASIMIROIN AND ITS ANALOGS BOUND TO HUMAN QUINONE REDUCTASE 2 |
3NHR | A:; B: | X-RAY CRYSTALLOGRAPHIC STRUCTURE ACTIVITY RELATIONSHIP (SAR) OF CASIMIROIN AND ITS ANALOGS BOUND TO HUMAN QUINONE REDUCTASE 2 |
3NHS | A:; B: | X-RAY CRYSTALLOGRAPHIC STRUCTURE ACTIVITY RELATIONSHIP (SAR) OF CASIMIROIN AND ITS ANALOGS BOUND TO HUMAN QUINONE REDUCTASE 2 |
3NHU | A:; B: | X-RAY CRYSTALLOGRAPHIC STRUCTURE ACTIVITY RELATIONSHIP (SAR) OF CASIMIROIN AND ITS ANALOGS BOUND TO HUMAN QUINONE REDUCTASE 2 |
3NHW | A:; B: | X-RAY CRYSTALLOGRAPHIC STRUCTURE ACTIVITY RELATIONSHIP (SAR) OF CASIMIROIN AND ITS ANALOGS BOUND TO HUMAN QUINONE REDUCTASE 2 |
3NHY | A:; B: | X-RAY CRYSTALLOGRAPHIC STRUCTURE ACTIVITY RELATIONSHIP (SAR) OF CASIMIROIN AND ITS ANALOGS BOUND TO HUMAN QUINONE REDUCTASE 2 |
3O2N | A:; B: | X-RAY CRYSTALLOGRAPHIC STRUCTURE ACTIVITY RELATIONSHIP (SAR) OF CASIMIROIN AND ITS ANALOGS BOUND TO HUMAN QUINONE REDUCTASE 2 |
3O73 | A:; B: | CRYSTAL STRUCTURE OF QUINONE REDUCTASE 2 IN COMPLEX WITH THE INDOLEQUINONE MAC627 |
3OVM | A:; B: | X-RAY STRUCTURAL STUDY OF QUINONE REDUCTASE II INHIBITION BY COMPOUNDS WITH MICROMOLAR TO NANOMOLAR RANGE IC50 VALUES |
3OWH | A:; B: | X-RAY STRUCTURAL STUDY OF QUINONE REDUCTASE II INHIBITION BY COMPOUNDS WITH MICROMOLAR TO NANOMOLAR RANGE IC50 VALUES |
3OWX | A:; B: | X-RAY STRUCTURAL STUDY OF QUINONE REDUCTASE II INHIBITION BY COMPOUNDS WITH MICROMOLAR TO NANOMOLAR RANGE IC50 VALUES |
3OX1 | A:; B: | X-RAY STRUCTURAL STUDY OF QUINONE REDUCTASE II INHIBITION BY COMPOUNDS WITH MICROMOLAR TO NANOMOLAR RANGE IC50 VALUES |
3OX2 | A:; B: | X-RAY STRUCTURAL STUDY OF QUINONE REDUCTASE II INHIBITION BY COMPOUNDS WITH MICROMOLAR TO NANOMOLAR RANGE IC50 VALUES |
3OX3 | A:; B: | X-RAY STRUCTURAL STUDY OF QUINONE REDUCTASE II INHIBITION BY COMPOUNDS WITH MICROMOLAR TO NANOMOLAR RANGE IC50 VALUES |
3TE7 | A:; B: | QUINONE OXIDOREDUCTASE (NQ02) BOUND TO THE IMIDAZOACRIDIN-6-ONE 5A1 |
3TEM | A:; B: | QUINONE OXIDOREDUCTASE (NQ02) BOUND TO THE IMIDAZOACRIDIN-6-ONE 6A1 |
3TZB | A:; B:; C:; D: | QUINONE OXIDOREDUCTASE (NQ02) BOUND TO NSC13000 |
3UXE | A:; B: | DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF POTENT QUINOLINE AND PYRROLOQUINOLINE AMMOSAMIDE ANALOGUES AS INHIBITORS FOR QUINONE REDUCTASE 2 |
3UXH | A:; B: | DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF POTETENT QUINOLINE AND PYRROLOQUINOLINE AMMOSAMIDE ANALOGUES AS INHIBITORS OF QUINONE REDUCTASE 2 |
4FGJ | A:; B: | OXIDIZED QUINONE REDUCTASE 2 IN COMPLEX WITH PRIMAQUINE |
4FGK | A:; B: | OXIDIZED QUINONE REDUCTASE 2 IN COMPLEX WITH CHLOROQUINE |
4FGL | A:; B:; C:; D: | REDUCED QUINONE REDUCTASE 2 IN COMPLEX WITH CHLOROQUINE |
4GQI | A:; B: | SYNTHESIS OF NOVEL MT3 RECEPTOR LIGANDS VIA UNUSUAL KNOEVENAGEL CONDENSATION |
4GR9 | A:; B: | SYNTHESIS OF NOVEL MT3 RECEPTOR LIGANDS VIA UNUSUAL KNOEVENAGEL CONDENSATION |